The Korean Journal of Cytopathology 13(1): 14-20, 2002

Size: px
Start display at page:

Download "The Korean Journal of Cytopathology 13(1): 14-20, 2002"

Transcription

1 13 1 The Korean Journal of Cytopathology 13(1): 14-20, 2002

2 : ASCUS 1941 Papanicolaou. The Bethesda System(TBS) 1) 1988, atypical squamous cells of undetermined significance(ascus), low-grade squamous intraepithelial lesion(lsil), high-grade squamous intraepithelial lesion(hsil), squamous cell carcinoma. ASCUS SIL, SIL ASCUS. 2) ASCUS SIL, 3-6) TBS ASCUS (ASCUS, favor reactive) SIL (ASCUS, favor SIL). 7) ASCUS, SIL ASCUS ASCUS SIL. 8-10) LSIL 11,12) HSIL ASCUS 13) ASCUS SIL HSIL ASCUS(ASCUS, R/O HSIL), 2001 TBS ASCUS ASC-US(atypical squamous cells of undetermined significance) ASC-H(atypical squamous cells cannot exclude HSIL). ASCUS, R/O HSIL HSIL HPV DNA test ASCUS, not otherwise specified(nos) ASCUS. ASCUS, R/O HSIL, ASCUS, R/O HSIL ASCUS, R/O SIL 275 ASCUS, R/O LSIL 174 HSIL , , 47 hybrid capture (Hybrid Capture II, Digene, USA) HPV DNA. HPV DNA ASCUS, NOS 89. Chi square p <0.05. ASCUS, R/O HSIL,,,,. 35.6% 36.6%,,, (Table 1).,,.

3 / 13 / 1 / (Fig. 2), (Fig. 3),. HSIL (Fig. 4), (Fig. 5). (Fig. 1) 87, LSIL, HSIL, 39.1%, 4.6%, 54%, 2.3%,. ASCUS, NOS 89, LSIL, HSIL 69.7%, 15.7%, 14.6% ASCUS, R/O HSIL HSIL (p =0.000)(Table 2).

4 : ASCUS 47 ASCUS, R/O HSIL 60 ASCUS, reactive HPV DNA, 57.4% 60.0% TBS -Pap class I-IV, cervical intraepithelial lesion (CIN) I-III, dysplasia -. TBS atypical sqaumous cells of undetermined significance " SIL ",

5 / 13 / 1 / 2002, Bethesda Workshop ASCUS SIL. 7) ASCUS, ASCUS SIL. Sidawy 3) "atypia" 88 ASCUS, 5.2% 61.3% SIL ASCUS SIL. Williams 5) ASCUS 28, 58% SIL 49% LSIL. ASCUS LSIL. Lachman 6) Carvallo-Calcanese ASCUS % 203 SIL, 109 LSIL, 94 HSIL. ASCUS, NOS 30.3% SIL HSIL. ASCUS SIL, 14) ASCUS favor SIL favor reactive. TBS ASCUS SIL, ASCUS. Kline Davey 8) ASCUS favor reactive, favor dysplasia unqualified SIL, SIL 29.5%, 46.5%, 26.2% ASCUS, favor dysplasia. Collins 9) ASCUS, ASCUS favor reactive, ASCUS favor SIL, LSIL 435. SIL ASCUS, ASCUS favor reactive, ASCUS favor SIL, LSIL 10%, 28%, 36%, 55%, ASCUS favor reactive ASCUS ASCUS favor SIL SIL. ASCUS, favor SIL HSIL 15% ASCUS, reactive ASCUS HSIL, ASCUS, favor SIL LSIL. Vlahos 10) SIL ASCUS ASCUS SIL41.1% 22.3%, HSIL SIL ASCUS 9.7. SIL ASCUS. ASCUS SIL, SIL ASCUS LSIL. LSIL 11,12) HSIL, SIL ASCUS HSIL, HSIL ASCUS 13), HSIL HSIL ASCUS. ChangChien 15) ASCUS HISL HSIL 77.0% 3.8%, Genest 16) ASCUS favor reactive, not otherwise specified, favor SIL, favor HSIL ASCUS, favor HSIL HSIL.

6 : ASCUS ASCUS, NOS ASCUS, R/O HSIL HSIL 56.3% 14.6%. ASCUS, R/O HSIL, HSIL ASCUS. ASCUS, favor SIL ASCUS, R/O HSIL TBS, ASCUS SIL. Morin 17) ASCUS 36 LSIL HSIL, LSIL, HSIL,,,. Sheils Wilbur 18) ASCUS SIL, HSIL, Montes 19) HSIL. HSIL. ASCUS, R/O HSIL Sherman 20),,,, 21.3% 17.3%.,, Sherman 20), 36.6% 35.6%.. Sheils Wilbur 18) Montes 19) 18.8%.,,. ASCUS, NOS ASCUS, R/O HSIL HPV DNA, HPV HPV HSIL 101. ASCUS, R/O HSIL ASCUS, NOS HPV DNA test ASCUS. ASCUS, R/O HSIL,,,,, 35.6% 36.6%. ASCUS, R/O HSIL ASCUS, NOS HSIL. ASCUSHSIL.

7 / 13 / 1 / NCI Workshop: The 1988 Bethesda System for reporting cervical/vaginal cytological diagnosis. JAMA 262: , Kurman RJ, Solomon D: The Bethesda System for Reporting Cervical/Vaginal Cytologic Diagnoses. New York, Springer-Verlag, 1994, pp Sidawy MK, Tabbara SO: Reactive change and atypical squamous cells of undetermined significance in Papanicolaou smears: A cytohistologic correlation. Diagn Cytopathol 9: , Howell LP, Davis RL: Follow-up of Papanicolaou smears diagnosed as atypical squamous cells of undetermined significance. Diagn Cytopathol 14:20-24, Williams ML, Rimm DL, Pedigo MA, Frable WJ: Atypical squamous cells of undeterined significance: Correlative histologic and follow-up studies from an academic medical center. Diagn Cytopathol 16:1-7, Lachman MF, Cavallo-Calcanese C: Qualification of atypical squamous cells of undetermined significance in an independent laboratory: Is it useful or significant? Am J Obstet Gynecol 179: , National Cancer Institute Workshop. The Bethesda system for reporting cervical/vaginal cytologic diagnoses:report of the 1991 Bethesda Workshop. JAMA 267:1892, Kline MJ, Davey DD: Atypical squamous cells of undetermined significance qualified: A follow-up study. Diagn Cytopathol 14: , Collins LC, Wang HH, Abu-Jawdeh AM: Qualifiers of atypical squamous cells of undetermined significance help in patient management. Mod Pathol 9: , Vlahos NP, Dragisic KG, Wallach EE, Burroughs FH, Fluck S, Rosenthal DL: Clinical significance of the qualification of atypical squamous cells of undetermined significance: An analysis on the basis of histologic diagnoses. Am J Obstet Gynecol 182: , Lee SS, Collins RJ, Pun TC, Cheng DK, Ngan HY: Conservative treatment of low grade squamous intraepithelial lesions (LSIL) of the cervix. Int J Gynecol Pathol 60:35-40, Falls RK: Spontaneous resolution rate of grade 1 cervical intraepithelial neoplasia in a private practice population. Am J Obstet Gynecol 181: , Kinney WK, Manos MM, Hurley LB, Ransley JE: Where's the high-grade cervical neoplasia? The importance of minimally abnormal Papanicolaou diagnoses. Obstet Gynecol 91: , Yang M, Zachariah S: ASCUS on cervical cytologic smears: Clinical significance. J Reprod Med 42: , ChangChien CC, Lin H, Eng HL, Chang WK: Clinical implication of atypical squamous cells of undetermined significance with or without favoring high-grade squamous intraepithelial lesion on cervical smear (abstract). Changgeng Yi Xue Za Ahi 22: , Genest DR, Dean B, Lee KR, Sheets E, Crum CP, Cibas ES: Qualifying the cytologic diagnosis of "atypical squamous cells of undetermined significance" affects the predictive value of a squamous intraepithelial lesion on subsequent biopsy. Arch Pathol Lab Med 122: , Morin C, Bairati I, Bouchard C, et al.: Cytologic predictors of cervical intraepithelial neoplasia in women with an ASCUS pap smear. Acta Cytol 44: , Sheils LA, Wilbur DC: Atypical squamous cells of undetermined significance: Stratification of the association with, or progression to, squamous intraepithelial lesions based on morphologic subcategorization. Acta Cytol 41: , Montes MA, Cibas ES, DiNixco SA, Lee KR: Cytologic characteristics of abnormal cells in prior "normal" cervical/vaginal Papanicolaou smears from women with a high grade squamous intraepithelial lesion. Cancer 87:56-59, Sherman ME, Tabbara SO, Scott DR, et al.: "ASCUS, R/O HSIL": Cytologic features, histologic correlates, and human papillomavirus detection. Mod Pathol 12: ,1999

In 1988, the National Cancer Institute developed the Bethesda System. Atypical Squamous Cells of Undetermined Significance on Cervical Smears CANCER

In 1988, the National Cancer Institute developed the Bethesda System. Atypical Squamous Cells of Undetermined Significance on Cervical Smears CANCER 74 CANCER CYTOPATHOLOGY Atypical Squamous Cells of Undetermined Significance on Cervical Smears Follow-Up Study of an Asian Screening Population Annie N. Y. Cheung, M.D. Elaine F. Szeto, B.Sc. Kin-Man

More information

In 1988, The Bethesda System (TBS) introduced the phrase atypical

In 1988, The Bethesda System (TBS) introduced the phrase atypical CANCER CYTOPATHOLOGY 93 Should the Cytologic Diagnosis of Atypical Squamous Cells of Undetermined Significance Be Qualified? An Assessment Including Comparison between Conventional and Liquid-Based Technologies

More information

The diagnostic category of atypical squamous cells of undetermined

The diagnostic category of atypical squamous cells of undetermined 100 CANCER CYTOPATHOLOGY Significance of a Diagnosis of Atypical Squamous Cells of Undetermined Significance for Papanicolaou Smears in Perimenopausal and Postmenopausal Women Jeffrey T. Keating, M.D.

More information

Comparison of Diagnostic Cytomorphology of Atypical Squamous Cells in Liquid-Based Preparations and Conventional Smears

Comparison of Diagnostic Cytomorphology of Atypical Squamous Cells in Liquid-Based Preparations and Conventional Smears The Korean Journal of Pathology 2012; 46: 365-369 ORIGINAL ARTICLE Comparison of Diagnostic Cytomorphology of Atypical Squamous Cells in Liquid-Based Preparations and Conventional Smears Jung Dal Lee 1,2

More information

Outcome of Atypical Squamous Cells in Cervical Cytology: Follow-up Assessment by Loop Electrical Excision Procedure

Outcome of Atypical Squamous Cells in Cervical Cytology: Follow-up Assessment by Loop Electrical Excision Procedure The Korean Journal of Pathology 2012; 46: 359-364 ORIGINAL ARTICLE Outcome of Atypical Squamous Cells in Cervical Cytology: Follow-up Assessment by Loop Electrical Excision Procedure Joon Seon Song Ilseon

More information

Atypical Glandular Cells of Undetermined Significance Outcome Predictions Based on Human Papillomavirus Testing

Atypical Glandular Cells of Undetermined Significance Outcome Predictions Based on Human Papillomavirus Testing Anatomic Pathology / ATYPICAL GLANDULAR CELLS AND HUMAN PAPILLOMAVIRUS Atypical Glandular Cells of Undetermined Significance Outcome Predictions Based on Human Papillomavirus Testing Jeffrey F. Krane,

More information

INTRODUCTION HSIL AND CERVICAL CARCINOMA IN ASCUS CERVICAL CYTOLOGY

INTRODUCTION HSIL AND CERVICAL CARCINOMA IN ASCUS CERVICAL CYTOLOGY HSIL AND CERVICAL CARCINOMA IN ASCUS CERVICAL CYTOLOGY PREVALENCE OF HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESIONS (HSIL) AND INVASIVE CERVICAL CANCER IN PATIENTS WITH ATYPICAL SQUAMOUS CELLS OF UNDETERMINED

More information

Long-Term Outcome and Relative Risk in Women With Atypical Squamous Cells of Undetermined Significance

Long-Term Outcome and Relative Risk in Women With Atypical Squamous Cells of Undetermined Significance Anatomic Pathology / LONG-TERM OUTCOME WITH ATYPICAL SQUAMOUS CELLS OF UNDETERMINED SIGNIFICANCE Long-Term Outcome and Relative Risk in Women With Atypical Squamous Cells of Undetermined Significance Stephen

More information

PAP SMEAR WITH ATYPICAL SQUAMOUS CELLS OF UNDETERMINED SIGNIFICANCE

PAP SMEAR WITH ATYPICAL SQUAMOUS CELLS OF UNDETERMINED SIGNIFICANCE Arch Iranian Med 2005; 8 (3): 192 196 Original Article PAP SMEAR WITH ATYPICAL SQUAMOUS CELLS OF UNDETERMINED SIGNIFICANCE Fatemeh Ghaemmaghami MD *, Fereshteh Ensani MD**, Nadereh Behtash MD* Ebrahim

More information

Evaluation of Low-Grade Squamous Intraepithelial Lesions, Cannot Exclude High-Grade Squamous Intraepithelial Lesions on Cervical Smear

Evaluation of Low-Grade Squamous Intraepithelial Lesions, Cannot Exclude High-Grade Squamous Intraepithelial Lesions on Cervical Smear The Korean Journal of Pathology 2010; 44: 528-35 DOI: 10.4132/KoreanJPathol.2010.44.5.528 Evaluation of Low-Grade Squamous Intraepithelial Lesions, Cannot Exclude High-Grade Squamous Intraepithelial Lesions

More information

Awatif Al-Nafussi, Gemma Rebello, Raja Al-Yusif, Euphemia McGoogan

Awatif Al-Nafussi, Gemma Rebello, Raja Al-Yusif, Euphemia McGoogan J Clin Pathol 2000;53:439 444 439 Papers Department of Pathology, Medical School, Teviot Place, Edinburgh EH8 9AG, UK A Al-Nafussi G Rebello R Al-Yusif E McGoogan Correspondence to: Dr Al-Nafussi email:

More information

Atypical squamous cells. The case for HPV testing

Atypical squamous cells. The case for HPV testing OBG MANAGEMENT FOCUS ON CERVICAL DISEASE BY J. THOMAS COX, MD ASC-US is most often due to transient changes or HPV. HPV-positive ASC-US is 12.5 to 23 times more likely to be associated with CIN 2,3 on

More information

Biomed Environ Sci, 2015; 28(1): 80-84

Biomed Environ Sci, 2015; 28(1): 80-84 80 Biomed Environ Sci, 2015; 28(1): 80-84 Letter to the Editor Assessing the Effectiveness of a Cervical Cancer Screening Program in a Hospital-based Study* YANG Yi1, LANG Jing He1, WANG You Fang1, CHENG

More information

Cervical Screening for Dysplasia and Cancer in Patients with HIV

Cervical Screening for Dysplasia and Cancer in Patients with HIV Cervical Screening for Dysplasia and Cancer in Patients with HIV Adult Clinical Guideline from the New York State Department of Health AIDS Institute w w w.hivg uidelines.org Purpose of the Guideline Increase

More information

Negative Colposcopic Biopsy After Positive Human Papilloma Virus (HPV) DNA Testing False-Positive HPV Results or False-Negative Histologic Findings?

Negative Colposcopic Biopsy After Positive Human Papilloma Virus (HPV) DNA Testing False-Positive HPV Results or False-Negative Histologic Findings? Anatomic Pathology / FALSE-NEGATIVE HISTOLOGIC FINDINGS Negative Colposcopic Biopsy After Positive Human Papilloma Virus (HPV) DNA Testing False-Positive HPV Results or False-Negative Histologic Findings?

More information

HKCOG GUIDELINES NUMBER 3 (revised November 2002) published by The Hong Kong College of Obstetricians and Gynaecologists

HKCOG GUIDELINES NUMBER 3 (revised November 2002) published by The Hong Kong College of Obstetricians and Gynaecologists HKCOG Guidelines Guidelines on the Management of An Abnormal Cervical Smear Number 3 revised November 2002 published by The Hong Kong College of Obstetricians and Gynaecologists A Foundation College of

More information

HPV Testing & Cervical Cancer Screening:

HPV Testing & Cervical Cancer Screening: HPV Testing & Cervical Cancer Screening: Are they linked? By William Chapman, MD, FRCPC Screening for precursor lesions of cervical cancer by the Papanicolaou (Pap) smear has been one of the greatest success

More information

Comparative study of human papilloma virus DNA detection and results of histopathological examination of cervical colposcopic biopsy

Comparative study of human papilloma virus DNA detection and results of histopathological examination of cervical colposcopic biopsy Iranian Journal of Reproductive Medicine Vol.5. No.3. pp:121-126, Summer 2007 Comparative study of human papilloma virus DNA detection and results of histopathological examination of cervical colposcopic

More information

Understanding Your Pap Test Results

Understanding Your Pap Test Results Understanding Your Pap Test Results Most laboratories in the United States use a standard set of terms called the Bethesda System to report pap test results. Normal: Pap samples that have no cell abnormalities

More information

A Cytologic/Histologic Review of 367 Cases. Original Article. Cancer Cytopathology August 25,

A Cytologic/Histologic Review of 367 Cases. Original Article. Cancer Cytopathology August 25, Correlation Between Hybrid Capture II High-Risk Human Papillomavirus DNA Test Chemiluminescence Intensity From Cervical Samples With Follow-Up Histologic Results A Cytologic/Histologic Review of 367 Cases

More information

Colposcopy. Attila L Major, MD, PhD

Colposcopy. Attila L Major, MD, PhD Colposcopy Attila L Major, MD, PhD Histology Colposcopy Cytology It has been estimated that annual Pap smear testing reduces a woman s chance of dying of cervical cancer from 4 in 1000 to about 5 in 10,000

More information

Faculty Pap Smear Guidelines: Family Planning Update 2008 Part Two

Faculty Pap Smear Guidelines: Family Planning Update 2008 Part Two Faculty Pap Smear Guidelines: Family Planning Update 2008 Part Two Seshu P. Sarma, MD, FAAP Emory University Regional Training Center Atlanta, Georgia Produced by the Alabama Department of Public Health

More information

Atypical Epithelial Cells and Specimen Adequacy

Atypical Epithelial Cells and Specimen Adequacy Atypical Epithelial Cells and Specimen Adequacy Current Laboratory Practices of Participants in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology Diane

More information

Cervical cytology screening has led to a reduction in cancer mortality

Cervical cytology screening has led to a reduction in cancer mortality CANCER CYTOPATHOLOGY 105 ThinPrep Pap Test Performance and Biopsy Follow-Up in a University Hospital A. Betts Carpenter, M.D., Ph.D. Diane D. Davey, M.D. Department of Pathology and Laboratory Medicine,

More information

Should Anal Pap Smears Be a Standard of Care in HIV Management?

Should Anal Pap Smears Be a Standard of Care in HIV Management? Should Anal Pap Smears Be a Standard of Care in HIV Management? Gordon Dickinson, M.D., FACP Professor of Medicine and Chief Infectious Diseases, Miller School of Medicine Short Answer: NO But 15-20 HPV

More information

The AutoPap Primary Screening System (APSS; Tripath Imaging,

The AutoPap Primary Screening System (APSS; Tripath Imaging, CANCER CYTOPATHOLOGY 129 A Feasibility Study of the Use of the AutoPap Screening System as a Primary Screening and Location-Guided Rescreening Device Massimo Confortini, M.D. 1 Lucia Bonardi, M.D. 1 Paolo

More information

Detecting High-Grade Cervical Disease on ASC-H Cytology. Role of BD ProEx C and Digene Hybrid Capture II HPV DNA Testing

Detecting High-Grade Cervical Disease on ASC-H Cytology. Role of BD ProEx C and Digene Hybrid Capture II HPV DNA Testing Anatomic Pathology / BD ProEx C Use in ASC-H Cy t o l o g y Detecting High-Grade Cervical Disease on ASC-H Cytology Role of BD ProEx C and Digene Hybrid Capture II HPV DNA Testing Momin T. Siddiqui, MD,

More information

CAP Laboratory Improvement Programs

CAP Laboratory Improvement Programs CAP Laboratory Improvement Programs Practices of Participants in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology, 2006 Galen M. Eversole, MD; Ann T. Moriarty,

More information

The Bethesda System for Reporting Cervical Cytology: A Historical Perspective

The Bethesda System for Reporting Cervical Cytology: A Historical Perspective Commentary Received: May 17, 2017 Accepted after revision: May 18, 2017 Published online: July 11, 2017 The Bethesda System for Reporting Cervical Cytology: A Historical Perspective Ritu Nayar a David

More information

BC Cancer Cervix Screening 2015 Program Results. February 2018

BC Cancer Cervix Screening 2015 Program Results. February 2018 BC Cancer Cervix Screening 2015 Program Results BC Cancer Cervix Screening 2015 Program Results 2 Table of Contents BC Cancer Cervix Screening 2015 Program Results... 1 Table of Contents... 2 Program Overview...

More information

GYN (Glandulars) Still Difficult After All These Years! Dina R Mody, MD Director of Cytology Laboratories and fellowship Program Methodist Hospital

GYN (Glandulars) Still Difficult After All These Years! Dina R Mody, MD Director of Cytology Laboratories and fellowship Program Methodist Hospital GYN (Glandulars) Still Difficult After All These Years! Dina R Mody, MD Director of Cytology Laboratories and fellowship Program Methodist Hospital and Bioreference Labs (Houston) Department of Pathology

More information

Human Papillomavirus Testing Using Hybrid Capture II With SurePath Collection

Human Papillomavirus Testing Using Hybrid Capture II With SurePath Collection 468 Human Papillomavirus Testing Using Hybrid Capture II With SurePath Collection Initial Evaluation and Longitudinal Data Provide Clinical Validation for This Method Vincent Ko, MD Rosemary H. Tambouret,

More information

Human papillomavirus typing in HIV-positive women

Human papillomavirus typing in HIV-positive women Infect Dis Obstet Gynecol ;9:89 93 Human papillomavirus typing in HIV-positive women Meera Hameed, Helen Fernandes, Joan Skurnick, Dorothy Moore, Patricia Kloser 3 and Debra Heller Department of Pathology

More information

Chapter 14: Role of Triage Testing in Cervical Cancer Screening

Chapter 14: Role of Triage Testing in Cervical Cancer Screening Chapter 14: Role of Triage Testing in Cervical Cancer Screening Diane Solomon The classic model of cervical cancer prevention primary screening with cytology, followed by diagnostic colposcopically directed

More information

Cervical Precancer: Evaluation and Management

Cervical Precancer: Evaluation and Management TAJ June 2002; Volume 15 Number 1 ISSN 1019-8555 The Journal of Teachers Association RMC, Rajshahi Review fam Cervical Precancer: Evaluation and Management SM Khodeza Nahar Begum 1 Abstract Carcinoma of

More information

Appropriate Use of Cytology and HPV Testing in the New Cervical Cancer Screening Guidelines

Appropriate Use of Cytology and HPV Testing in the New Cervical Cancer Screening Guidelines Appropriate Use of Cytology and HPV Testing in the New Cervical Cancer Screening Guidelines Tim Kremer, MD Ralph Anderson, MD 1 Objectives Describe the natural history of HPV particularly as it relates

More information

Can HPV-16 Genotyping Provide a Benchmark for Cervical Biopsy Specimen Interpretation?

Can HPV-16 Genotyping Provide a Benchmark for Cervical Biopsy Specimen Interpretation? Anatomic Pathology / Monitoring HPV-16 Fractions in CIN Can HPV-16 Genotyping Provide a Benchmark for Cervical Biopsy Specimen Interpretation? Mary T. Galgano, MD, 1 Philip E. Castle, PhD, MPH, 2 Mark

More information

Lessons From Cases of Screened Women Who Developed Cervical Carcinoma

Lessons From Cases of Screened Women Who Developed Cervical Carcinoma Lessons From Cases of Screened Women Who Developed Cervical Carcinoma R. Marshall Austin MD,PhD Magee-Womens Hospital of University of Pittsburgh Medical Center raustin@magee.edu Why Focus Study On Cases

More information

ANALYSES OF CERVICAL CANCER IN RAJKOT POPULATION

ANALYSES OF CERVICAL CANCER IN RAJKOT POPULATION Electronic Journal of Pharmacology and Therapy Vol 4, 15-20 (2011) ISSN: 0973-9890 (Available online at wwwtcrjournalscom) Clinical Article ndexed in: ProQuest database Abstract, USA (ProQuest Science

More information

Received April 22, 2012; accepted May 17, 2012; Epub May 23, 2012; Published June 30, 2012

Received April 22, 2012; accepted May 17, 2012; Epub May 23, 2012; Published June 30, 2012 Int J Clin Exp Pathol 22;5(5):428-435 www.ijcep.com /ISSN: 936-2625/IJCEP24 Original Article Atypical squamous cells of undetermined significance in patients with HPV positive DNA testing and correlation

More information

PAP SMEAR by Dr.Shantha Krishnamurthy MD Senior Consultant Pathology Fortis Hospitals

PAP SMEAR by Dr.Shantha Krishnamurthy MD Senior Consultant Pathology Fortis Hospitals PAP SMEAR by Dr.Shantha Krishnamurthy MD Senior Consultant Pathology Fortis Hospitals Historical Named after George Papanicolaou, a Greek American Studied cervical epithelium in menstrual cycle of guinea

More information

Abnormal Cervicovaginal Cytology With Negative Human Papillomavirus Testing

Abnormal Cervicovaginal Cytology With Negative Human Papillomavirus Testing 280 Abnormal Cervicovaginal Cytology With Negative Human Papillomavirus Testing Giovanni Negri, MD Bettina Rigo, BS Fabio Vittadello, ScD Christine Mian, ScD Eduard Egarter-Vigl, MD Department of Pathology,

More information

Comparative Study of Pap Smear and Cervical Biopsy Findings

Comparative Study of Pap Smear and Cervical Biopsy Findings Original paper Comparative Study of Pap Smear and Cervical Biopsy Findings ^* ^Department of pathology/ College of medicine/ Kerbala University/Kerbala/ Iraq. Abstract B ackground: Pap smear is the most

More information

Utility of Pap Smear in Cervical Screening in a Tertiary Care Hospital

Utility of Pap Smear in Cervical Screening in a Tertiary Care Hospital International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 6 Number 1 (2017) pp. 319-323 Journal homepage: http://www.ijcmas.com Original Research Article http://dx.doi.org/10.20546/ijcmas.2017.601.039

More information

Reporting Endometrial Cells in Women 40 Years and Older Assessing the Clinical Usefulness of Bethesda 2001

Reporting Endometrial Cells in Women 40 Years and Older Assessing the Clinical Usefulness of Bethesda 2001 Anatomic Pathology / THE EFFECT OF BETHESDA 2001 ON REPORTING OF ENDOMETRIAL CELLS Reporting Endometrial Cells in Women 40 Years and Older Assessing the Clinical Usefulness of Bethesda 2001 Aylin Simsir,

More information

CAP Laboratory Improvement Programs

CAP Laboratory Improvement Programs CAP Laboratory Improvement Programs Comparison of Performance of Conventional and ThinPrep Gynecologic Preparations in the College of American Pathologists Gynecologic Cytology Program Andrew A. Renshaw,

More information

The Korean Journal of Cytopathology 15 (1) : 17-27, 2004

The Korean Journal of Cytopathology 15 (1) : 17-27, 2004 5 The Korean Journal of Cytopathology 5 () : 7-7, / 5 / / (human papillomavirus, HPV), 6%, 5% HPV. HPV HPV. HPV HPV,,5 HPV HPV. HPV, 6 HPV. HPV HPV International Agency for Research on Cancer (IARC) HPV

More information

The Bethesda System: Updates for th Cytopathology Congress Bursa, Turkey October 14, 2015

The Bethesda System: Updates for th Cytopathology Congress Bursa, Turkey October 14, 2015 HARVARD MEDICAL SCHOOL The Bethesda System: Updates for 2015 6th Cytopathology Congress Bursa, Turkey October 14, 2015 David C. Wilbur, M.D. Dept. of Pathology Massachusetts General Hospital DISCLOSURES

More information

CME/SAM. Follow-up Outcomes in a Large Cohort of Patients With Human Papillomavirus Negative ASC-H Cervical Screening Test Results

CME/SAM. Follow-up Outcomes in a Large Cohort of Patients With Human Papillomavirus Negative ASC-H Cervical Screening Test Results Anatomic Pathology / HPV-Negative ASC-H Follow-up Outcomes in a Large Cohort of Patients With Human Papillomavirus Negative ASC-H Cervical Screening Test Results David Cohen, MD, R. Marshall Austin, MD,

More information

Absolute Risk of a Subsequent Abnormal Pap among Oncogenic Human Papillomavirus DNA-Positive, Cytologically Negative Women

Absolute Risk of a Subsequent Abnormal Pap among Oncogenic Human Papillomavirus DNA-Positive, Cytologically Negative Women Absolute Risk of a Subsequent Abnormal Pap among Oncogenic Human Papillomavirus DNA-Positive, Cytologically Negative Women 2145 Philip E. Castle, Ph.D., M.P.H. 1 Sholom Wacholder, Ph.D. 1 Mark E. Sherman,

More information

(Pap) results, ie, abnormal squamous cells of undetermined significance (ASCUS). According to

(Pap) results, ie, abnormal squamous cells of undetermined significance (ASCUS). According to The Role of Human Papillomavirus Type 16/18 Genotyping in Predicting High-Grade Cervical/Vaginal Intraepithelial Neoplasm in Women With Mildly Abnormal Papanicolaou Results Ming Guo, MD 1 ; Yun Gong, MD

More information

Human papiloma virus testing in the cervix of high-risk women: A hospital-based clinicopathological, colposcopic, and cytogenetic study

Human papiloma virus testing in the cervix of high-risk women: A hospital-based clinicopathological, colposcopic, and cytogenetic study Research Article Human papiloma virus testing in the cervix of high-risk women: A hospital-based clinicopathological, colposcopic, and cytogenetic study Subhash Bhardwaj 1, Farooq Ahmed Wani 2, Altaf Bandy

More information

Philip E. Castle, Diane Solomon, Mark Schiffman, Cosette M. Wheeler for the ALTS Group

Philip E. Castle, Diane Solomon, Mark Schiffman, Cosette M. Wheeler for the ALTS Group ARTICLEARTICLESHuman Papillomavirus Type 16 Infections and 2-Year Absolute Risk of Cervical Precancer in Women With Equivocal or Mild Cytologic Abnormalities Philip E. Castle, Diane Solomon, Mark Schiffman,

More information

High-risk Human Papillomavirus Infection in Low Risk Women: Incidence, Patient Characteristics, and Clinical Meaning for Cervical Cancer

High-risk Human Papillomavirus Infection in Low Risk Women: Incidence, Patient Characteristics, and Clinical Meaning for Cervical Cancer 103 Ivyspring International Publisher Research Paper International Journal of Medical Sciences 2012; 9(1):103-107 High-risk Human Papillomavirus Infection in Low Risk Women: Incidence, Patient Characteristics,

More information

International Journal of Biological & Medical Research

International Journal of Biological & Medical Research Int J Biol Med Res. ; 2(3): 757-761 Int J Biol Med Res www.biomedscidirect.com Volume 2, Issue 3, July BioMedSciDirect Publications Contents lists available at BioMedSciDirect Publications International

More information

ICD-9-CM to ICD-10-CM DIAGNOSIS CODE MAPPING. Central Valley Public Health: Women's Way

ICD-9-CM to ICD-10-CM DIAGNOSIS CODE MAPPING. Central Valley Public Health: Women's Way ICD-9-CM to ICD-10-CM DIAGNOSIS CODE MAPPING Central Valley Public Health: Women's Way ICD-9-CM (Top 35) ICD-10-CM ICD-10-CM Description COMMENTS V10.3: Personal history of malignant neoplasm of Z85.3

More information

From the Department of Pathology, King Abdulaziz University Hospital, Jeddah, Saudi Arabia

From the Department of Pathology, King Abdulaziz University Hospital, Jeddah, Saudi Arabia Pattern of abnormal Pap smears in developing countries: A report from a large referral hospital in Saudi Arabia using the revised 2001 Bethesda System Layla S. Abdullah From the Department of Pathology,

More information

Vasile Goldiş Western University of Arad, Faculty of Medicine, Obstetrics- Gynecology Department, Romania b

Vasile Goldiş Western University of Arad, Faculty of Medicine, Obstetrics- Gynecology Department, Romania b Mædica - a Journal of Clinical Medicine ORIGINAL PAPERS Cervical Intraepithelial Neoplasia in the Dr. Salvator Vuia Clinical Obstetrics and Gynecology Hospital - Arad During the 2000-2009 Period Voicu

More information

Significance of High-Risk Human Papillomavirus DNA Detection in Women 50 Years and Older With Squamous Cell Papanicolaou Test Abnormalities

Significance of High-Risk Human Papillomavirus DNA Detection in Women 50 Years and Older With Squamous Cell Papanicolaou Test Abnormalities Significance of High-Risk Human Papillomavirus DNA Detection in Women 50 Years and Older With Squamous Cell Papanicolaou Test Abnormalities Chengquan Zhao, MD; Shuping Zhao, MD, PhD; Amer Heider, MD; R.

More information

Acceptable predictive accuracy of histopathology results by colposcopy done by Gynecology residents using Reid index

Acceptable predictive accuracy of histopathology results by colposcopy done by Gynecology residents using Reid index DOI 10.1007/s00404-012-2569-y GYNECOLOGIC ONCOLOGY Acceptable predictive accuracy of histopathology results by colposcopy done by Gynecology residents using Reid index Hadi Shojaei Fariba Yarandi Leila

More information

Effect of HIV Infection on Atypical Squamous Cells of Undetermined Significance

Effect of HIV Infection on Atypical Squamous Cells of Undetermined Significance MAJOR ARTICLE HIV/AIDS Effect of HIV Infection on Atypical Squamous Cells of Undetermined Significance Ann Duerr, 1 Pangaja Paramsothy, 2 Denise J. Jamieson, 3 Charles M. Heilig, 3 Robert S. Klein, 4 Susan

More information

Clinical Practice Guidelines June 2013

Clinical Practice Guidelines June 2013 Clinical Practice Guidelines June 2013 General Principles: The Papanicolaou (Pap) smear is widely credited with reducing mortality from cervical cancer, and remains the single best method for the early

More information

Medicine OPEN. Diagnostic Accuracy Study. 1. Introduction

Medicine OPEN. Diagnostic Accuracy Study. 1. Introduction Diagnostic Accuracy Study Medicine OPEN Clinical analysis of cervical intraepithelial neoplasia with vaginal intraepithelial neoplasia Yue He, MD, Qun Zhao, PhD, Yu-Ning Geng, MD, Shu-Li Yang, MD, Cheng-Hong

More information

chapter 4. The effect of oncogenic HPV on transformation zone epithelium

chapter 4. The effect of oncogenic HPV on transformation zone epithelium chapter 4. The effect of oncogenic HPV on transformation zone epithelium CHAPTER 1 All squamous cervical cancer (and probably all cervical adenocarcinoma) is associated with oncogenic HPV, and the absence

More information

Role of Micronucleus in Cervical Intraepithelial Lesions and Carcinoma

Role of Micronucleus in Cervical Intraepithelial Lesions and Carcinoma Original Article DOI: 10.21276/APALM.1354 Role of Micronucleus in Cervical Intraepithelial Lesions and Carcinoma Suganya Kuppovi Reddy 1 *, Surendra Kumar Verma 1, Sajini Elizabeth Jacob 1, Neelaiah Siddaraju

More information

Sydney Gynaecology Oncology Group, Sydney Cancer Centre, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia

Sydney Gynaecology Oncology Group, Sydney Cancer Centre, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia bs_bs_banner doi:10.1111/jog.12545 J. Obstet. Gynaecol. Res. Vol. 41, No. 3: 440 444, March 2015 Abnormal cervicovaginal cytology, unsatisfactory colposcopy and the use of vaginal estrogen cream: An observational

More information

ABSTRACT I N TRO D U CTI O N. Chapter 2

ABSTRACT I N TRO D U CTI O N. Chapter 2 Chapter 2 D etec tio n o f Cerv ic al In traepithelial N eo plas ia in w o m en w ith Aty pic al S q u am o u s o r G lan d u lar Cells o f U n d eterm in ed S ig n ific an c e c y to lo g y : A pro s

More information

Cytology/Biopsy/Leep Gynecologic Correlation: Practical Considerations and Approaches.

Cytology/Biopsy/Leep Gynecologic Correlation: Practical Considerations and Approaches. Cytology/Biopsy/Leep Gynecologic Correlation: Practical Considerations and Approaches. Fadi W. Abdul-Karim MD MEd. Professor of Pathology. Vice chair for education. Robert Tomsich Pathology and Lab Med

More information

Over-diagnoses in Cytopathology: Is histology the gold standard?

Over-diagnoses in Cytopathology: Is histology the gold standard? Over-diagnoses in Cytopathology: Is histology the gold standard? Teresa M. Darragh, MD UCSF Departments of Pathology and Obstetrics, Gynecology & Reproductive Sciences Faculty Disclosures: Teresa M. Darragh,

More information

Effect of human papillomavirus vaccination on cervical cancer screening in Alberta

Effect of human papillomavirus vaccination on cervical cancer screening in Alberta Effect of human papillomavirus vaccination on cervical cancer screening in Alberta Presenter: Jong Kim 1 Team: Christopher Bell 2, Maggie Sun 3, Gordon Kliewer 3, Linan Xu 3, Maria McInerney 4, Lawrence

More information

Making Sense of Cervical Cancer Screening

Making Sense of Cervical Cancer Screening Making Sense of Cervical Cancer Screening New Guidelines published November 2012 Tammie Koehler DO, FACOG The incidence of cervical cancer in the US has decreased more than 50% in the past 30 years because

More information

Cervical Screening Results Leading to Detection of Adenocarcinoma in Situ of the Uterine Cervix

Cervical Screening Results Leading to Detection of Adenocarcinoma in Situ of the Uterine Cervix DOI:10.31557/APJCP.2019.20.2.377 Cervical Screening Results Leading to Detecting Cervical AIS RESEARCH ARTICLE Editorial Process: Submission:09/27/2018 Acceptance:01/18/2019 Cervical Screening Results

More information

NILM Pap Slides From Women 30 Years of Age and Older With Positive High-Risk HPV DNA

NILM Pap Slides From Women 30 Years of Age and Older With Positive High-Risk HPV DNA NILM Pap Slides From Women 30 Years of Age and Older With Positive High-Risk HPV DNA Focused Rescreening Prior to Report Issuance, An Enhanced Quality Control Measure Karen Cormier, CT(ASCP), 1 Michael

More information

Cervical Cancer Screening for the Primary Care Physician for Average Risk Individuals Clinical Practice Guidelines. June 2013

Cervical Cancer Screening for the Primary Care Physician for Average Risk Individuals Clinical Practice Guidelines. June 2013 Cervical Cancer Screening for the Primary Care Physician for Average Risk Individuals Clinical Practice Guidelines General Principles: Since its introduction in 1943, Papanicolaou (Pap) smear is widely

More information

Cervical Cancer Screening Update. Melissa Hartman, DO Women s Health

Cervical Cancer Screening Update. Melissa Hartman, DO Women s Health Cervical Cancer Screening Update Melissa Hartman, DO Women s Health Previous Cervical Cancer Screening Organization Recommendation ACS (2011) ACP (2008) NCI (2003) Age 21 or 3 years after first intercourse

More information

Comparison of Human Papillomavirus Distribution in Cytologic Subgroups of Low-Grade Squamous Intraepithelial Lesion

Comparison of Human Papillomavirus Distribution in Cytologic Subgroups of Low-Grade Squamous Intraepithelial Lesion 288 Comparison of Human Papillomavirus Distribution in Cytologic Subgroups of Low-Grade Squamous Intraepithelial Lesion Rosemary E. Zuna, MD 1 Sophia S. Wang, PhD 2 Mark Schiffman, MD, MPH 2 Diane Solomon,

More information

Case Based Problems. Recommended Guidelines. Workshop: Case Management of Abnormal Pap Smears and Colposcopies. Disclosure

Case Based Problems. Recommended Guidelines. Workshop: Case Management of Abnormal Pap Smears and Colposcopies. Disclosure Disclosure Workshop: Case Management of Abnormal Pap Smears and Colposcopies Rebecca Jackson, MD Associate Professor Obstetrics, Gynecology & Reproductive Sciences and Epidemiology & Biostatistics This

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Garland SM, Hernandez-Avila M, Wheeler CM, et al. Quadrivalent

More information

Clinical Guidance: Recommended Best Practices for Delivery of Colposcopy Services in Ontario Best Practice Pathway Summary

Clinical Guidance: Recommended Best Practices for Delivery of Colposcopy Services in Ontario Best Practice Pathway Summary Clinical Guidance: Recommended Best Practices for Delivery of Colposcopy Services in Ontario Best Practice Pathway Summary Glossary of Terms Colposcopy is the examination of the cervix, vagina and, in

More information

HPV Genotyping: A New Dimension in Cervical Cancer Screening Tests

HPV Genotyping: A New Dimension in Cervical Cancer Screening Tests HPV Genotyping: A New Dimension in Cervical Cancer Screening Tests Lee P. Shulman MD The Anna Ross Lapham Professor in Obstetrics and Gynecology and Chief, Division of Clinical Genetics Feinberg School

More information

difficult and may not be practical. Nevertheless, the performance characteristics of rapid screening have not been completely characterized.

difficult and may not be practical. Nevertheless, the performance characteristics of rapid screening have not been completely characterized. Anatomic Pathology / PERFORMANCE CHARACTERISTICS OF RAPID PRESCREENING Performance Characteristics of Rapid (0-Second) Prescreening Implications for Calculating the False-Negative Rate and Comparison With

More information

Welcome. THE ROLE OF oncofish cervical ASSESSMENT OF CERVICAL DYSPLASIA. March 26, 2013

Welcome. THE ROLE OF oncofish cervical ASSESSMENT OF CERVICAL DYSPLASIA. March 26, 2013 THE ROLE OF oncofish cervical IN THE ASSESSMENT OF CERVICAL DYSPLASIA The phone lines will open, 15 minutes prior to the start of the webinar. Toll Free: 1-800-867-0864. Entry Code: 83956484. You may download

More information

International Journal of Health Sciences and Research ISSN:

International Journal of Health Sciences and Research   ISSN: International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Original Research Article Cytodiagnostic Study of Cervical Lesions Using the Bethesda System with Histopathological Tahera

More information

Chapter 10: Pap Test Results

Chapter 10: Pap Test Results Chapter 10: Pap Test Results On completion of this section, the learner will be able to: 1. Identify how Pap test results are interpreted and the reasons for normal and abnormal results. 2. Describe the

More information

WELL WOMAN CLINIC-SCREENING PROGRAM FOR CERVICAL CARCINOMAS G. J. Vani Padmaja 1

WELL WOMAN CLINIC-SCREENING PROGRAM FOR CERVICAL CARCINOMAS G. J. Vani Padmaja 1 WELL WOMAN CLINIC-SCREENING PROGRAM FOR CERVICAL CARCINOMAS G. J. Vani Padmaja 1 HOW TO CITE THIS ARTICLE: G. J. Vani Padmaja. Well Woman Clinic-Screening Program for Cervical Carcinomas. Journal of Evolution

More information

EU guidelines for reporting gynaecological cytology

EU guidelines for reporting gynaecological cytology EU guidelines for reporting gynaecological cytology Amanda Herbert Guy s & St Thomas Foundation NHS Trust 5th EFCS Annual Tutorial, Trondheim, Norway 28 th May 1 st June 2012 EU guidelines aim to harmonize

More information

Cytohistologic Discrepancies A Means to Improve Pathology Practice and Patient Outcomes

Cytohistologic Discrepancies A Means to Improve Pathology Practice and Patient Outcomes Anatomic Pathology / CYTOHISTOLOGIC DISCREPANCIES Cytohistologic Discrepancies A Means to Improve Pathology Practice and Patient Outcomes Karen M. Clary, MD, Jan F. Silverman, MD, Yulin Liu, MD, PhD, Charles

More information

JMSCR Vol 07 Issue 02 Page February 2019

JMSCR Vol 07 Issue 02 Page February 2019 www.jmscr.igmpublication.org Index Copernicus Value: 79.54 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v7i2.57 Study of cervical smears by conventional method using Bethesda

More information

Eradicating Mortality from Cervical Cancer

Eradicating Mortality from Cervical Cancer Eradicating Mortality from Cervical Cancer Michelle Berlin, MD, MPH Vice Chair, Obstetrics & Gynecology Associate Director, Center for Women s Health June 2, 2009 Overview Prevention Human Papilloma Virus

More information

HUMAN PAPILLOMAVIRUS TESTING

HUMAN PAPILLOMAVIRUS TESTING CLINICAL GUIDELINES For use with the UnitedHealthcare Laboratory Benefit Management Program, administered by BeaconLBS HUMAN PAPILLOMAVIRUS TESTING Policy Number: PDS - 016 Effective Date: October 1, 2018

More information

The Pap Test and Bethesda 2014

The Pap Test and Bethesda 2014 The Pap Test and Bethesda 2014 Ritu Nayar, MD 1 and David C. Wilbur, MD 2 The reports of my demise have been greatly exaggerated. (after a quotation from Mark Twain) The history of The Bethesda System

More information

Effectiveness of the ThinPrep Imaging System:

Effectiveness of the ThinPrep Imaging System: Effectiveness of the ThinPrep Imaging System: Clinical Experience in a Low Risk Screening Population Jacalyn L. Papillo, B.S., C.T., A.S.C.P., 1 * Timothy L. St. John, B.S., C.T., A.S.C.P., 1 and Gladwyn

More information

Agreement Between Cytotechnologists and Cytopathologists as a New Measure of Cytopathologist Performance in Gynecologic Cytology

Agreement Between Cytotechnologists and Cytopathologists as a New Measure of Cytopathologist Performance in Gynecologic Cytology Agreement Between Cytotechnologists and Cytopathologists as a New Measure of Cytopathologist Performance in Gynecologic Cytology Andrew M. Quinn, MD 1 ; Abu T. Minhajuddin, PhD 2 ; Linda S. Hynan, PhD

More information

What is a Pap smear?

What is a Pap smear? Pap smear What is a Pap smear? A Pap smear is a test that checks for changes in the cells of your cervix. The cervix is the lower part of the uterus that opens into the vagina. Developed over forty years

More information

GUIDELINE FOR SCREENING FOR CERVICAL CANCER: REVISED

GUIDELINE FOR SCREENING FOR CERVICAL CANCER: REVISED GUIDELINE FOR SCREENING FOR CERVICAL CANCER: REVISED This guideline is a revised version of the guideline developed in February 2000, by the Cervical Cancer Screening Working Group. This revised version

More information

Comparative Study of Pap Smear Quality by using Ayre s Spatula versus Ayre s Spatula and Cytobrush Combination

Comparative Study of Pap Smear Quality by using Ayre s Spatula versus Ayre s Spatula and Cytobrush Combination ORIGINAL ARTICLE Comparative Study of Pap Smear Quality by using Ayre s Spatula versus Ayre s Spatula and Cytobrush Combination Numi Anjum 1, B Sindhoora 2 1. Tutor, Department of Obstetrics and Gynecology

More information

Study of Cervical Pap Smears in a Tertiary Hospital

Study of Cervical Pap Smears in a Tertiary Hospital 250 Original Study Study of Cervical Pap Smears in a Tertiary Hospital Sunita A. Bamanikar, Professor, Department of Pathology, Dadaso S. Baravkar, Resident Pathologist, Department of Pathology, Shirish

More information

Can LBC Completely Replace Conventional Pap Smear in Developing Countries

Can LBC Completely Replace Conventional Pap Smear in Developing Countries The Journal of Obstetrics and Gynecology of India (January February 2019) 69(1):69 76 https://doi.org/10.1007/s13224-018-1-7 ORIGINAL ARTICLE Can LBC Completely Replace Conventional Pap Smear in Developing

More information

Dysplasia: layer of the cervical CIN. Intraepithelial Neoplasia. p16 immunostaining. 1, Cervical. Higher-risk, requires CIN.

Dysplasia: layer of the cervical CIN. Intraepithelial Neoplasia. p16 immunostaining. 1, Cervical. Higher-risk, requires CIN. CLINICAL PRACTICE GUIDELINE Guideline Number: DHMP_DHMC_PG1015 Guideline Subject: Routine Cervical Cancer Screening Effective Date: 9/2018 Revision Date: 9/2019 Pages: 2 of 2 Quality Management Committee

More information

Clinical Utility of Adjunctive High-Risk Human Papillomavirus DNA Testing in Women With Papanicolaou Test Findings of Atypical Glandular Cells

Clinical Utility of Adjunctive High-Risk Human Papillomavirus DNA Testing in Women With Papanicolaou Test Findings of Atypical Glandular Cells Clinical Utility of Adjunctive High-Risk Human Papillomavirus DNA Testing in Women With Papanicolaou Test Findings of Atypical Glandular Cells Chengquan Zhao, MD; Anca Florea, MD; R. Marshall Austin, MD,

More information